Clincosm LogoSign in Get a demo

tuberous sclerosis complex

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

Recruiting
  • Tuberous Sclerosis Complex
  • Acceptance and Commitment Therapy (ACT)
  • Bristol, United Kingdom
    University Hospitals Bristol and Weston NHS Trust
May 10, 2023

Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

Enrolling by invitation
  • Tuberous Sclerosis Complex
  • Phoenix, Arizona
  • +13 more
Jan 24, 2023

Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

Recruiting
  • Tuberous Sclerosis Complex
  • Basimglurant with crossover to Placebo
  • Placebo with crossover to Basimglurant
  • Phoenix, Arizona
  • +47 more
Jan 3, 2023

Studies in Patients With Tuberous Sclerosis Complex

Recruiting
  • Tuberous Sclerosis Complex
    • Phoenix, Arizona
      Translational Genomics Research Institute (TGen)
    Oct 18, 2022

    Tuberous Sclerosis Complex, Seizures Trial in Worldwide (GWP42003-P, Placebo)

    Completed
    Has Results
    • Tuberous Sclerosis Complex
    • Seizures
    • Birmingham, Alabama
    • +43 more
    Sep 22, 2022

    Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)

    Not yet recruiting
    • Tuberous Sclerosis Complex
    • Rapamycin
    • Placebo
    • Lodz, Poland
    • +1 more
    Sep 6, 2022

    Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

    Recruiting
    • Tuberous Sclerosis Complex
    • Epilepsy
    • Birmingham, Alabama
    • +7 more
    Sep 2, 2022

    Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

    Recruiting
    • Tuberous Sclerosis Complex
    • NPC-12Y gel
    • NPC-12Y placebo gel
    • Toyoake, Aichi, Japan
    • +4 more
    Aug 8, 2022

    Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex Trial in United States (Cannabidiol)

    Recruiting
    • Lennox Gastaut Syndrome
    • +2 more
    • Downey, California
    • +30 more
    Aug 4, 2022

    Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jul 20, 2022

    Lymphangioleiomyomatosis, a Study on Cathepsin K

    Recruiting
    • Lymphangioleiomyomatosis
    • Tuberous Sclerosis Complex
    • 24h urine
    • urine sample
    • Tours, France
      University hospital
    Jul 18, 2022

    Tuberous Sclerosis Complex, Seizures Trial in Boston (GWP42003-P)

    Completed
    Has Results
    • Tuberous Sclerosis Complex
    • Seizures
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 12, 2022

    Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)

    Active, not recruiting
    • Tuberous Sclerosis Complex
    • Birmingham, Alabama
    • +12 more
    May 4, 2022

    Resective Epilepsy Surgery for TRE

    Recruiting
    • Tuberous Sclerosis Complex
    • Epilepsy
      • Beijing, Beijing, China
        Beijing Children's Hospital
      Mar 6, 2022

      Tuberous Sclerosis Complex, Epilepsy Trial in Beijing

      Recruiting
      • Tuberous Sclerosis Complex
      • Epilepsy
        • Beijing, China
          Beijing Children's Hospital
        Mar 6, 2022

        Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

        Active, not recruiting
        • Tuberous Sclerosis Complex
        • Epilepsy
        • TAVT-18 (sirolimus)
        • Cincinnati, Ohio
          Cincinnati Children's Hospital
        Jan 10, 2022

        Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)

        Completed
        Has Results
        • Epilepsy
        • +2 more
        • New York, New York
          New York University Langone Medical Center
        Aug 31, 2021

        Tuberous Sclerosis Complex, Self-injury, Autism Trial in Baltimore (Sirolimus, Everolimus)

        Completed
        Has Results
        • Tuberous Sclerosis Complex
        • +2 more
        • Baltimore, Maryland
          Kennedy Krieger Institute
        Mar 26, 2021

        Autism in Infants With Tuberous Sclerosis Complex (TSC)

        Completed
        • Tuberous Sclerosis Complex
          • Birmingham, Alabama
          • +4 more
          Feb 2, 2021

          TSC1, TSC2, Tuberous Sclerosis Complex Trial in Boston, New York (Everolimus)

          Completed
          Has Results
          • TSC1
          • +3 more
          • Boston, Massachusetts
          • +1 more
          Sep 14, 2020

          Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Philadelphia (Simvastatin, Sirolimus Oral Product, Everolimus Oral

          Completed
          Has Results
          • Lymphangioleiomyomatosis
          • Tuberous Sclerosis Complex
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Aug 12, 2020

          Tuberous Sclerosis Complex, Aspirin, Epilepsy Trial in Beijing (Aspirin, AED, Placebo)

          Unknown status
          • Tuberous Sclerosis Complex
          • +4 more
          • Beijing, Beijing, China
            Department of Neurology, Peking Union Medical College Hospital
          Jun 5, 2020

          Dermatologic Patterns of Tuberous Sclerosis Patients and Somatic

          Unknown status
          • Tuberous Sclerosis Complex
            • Montpellier, France
              Uh Montpellier
            Mar 9, 2020

            Tuberous Sclerosis Complex Trial in Los Angeles (JASPER)

            Completed
            • Tuberous Sclerosis Complex
            • JASPER
            • Los Angeles, California
              UCLA Semel Insitute
            Apr 30, 2018

            Tuberous Sclerosis Complex Trial in Boston, Cincinnati (RAD001, Placebo)

            Completed
            Has Results
            • Tuberous Sclerosis Complex
            • Boston, Massachusetts
            • +1 more
            Jan 24, 2018